The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Sulfonamides; Indazoles; Pyrimidines; Angiogenesis Inhibitors; Disease-Free Survival; Double-Blind Method; Adult; Aged; Aged, 80 and over
PubMed ID
38531002
PubMed Central ID
PMC11514296
Added to directory
Source checked

Report a correction or request removal